Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury. - Wikidata - awgldk - TriplyDB

Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury.

Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury.

http://www.wikidata.org/entity/Q37336958

about

Nephrectomized and hepatectomized animal models as tools in preclinical pharmacokinetics Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline.Pharmacokinetics of tedizolid in subjects with renal or hepatic impairment.The 6R's of drug induced nephrotoxicity Antimicrobial dosing in acute renal replacement.Xenobiotic metabolism: the effect of acute kidney injury on non-renal drug clearance and hepatic drug metabolism Using drug probes to monitor hepatic drug metabolism in critically ill patients: midazolam, a flawed but useful tool for clinical investigation of CYP3A activity?Antibiotic dosing in critically ill patients with acute kidney injury.Renohepatic crosstalk: does acute kidney injury cause liver dysfunction?The effects of acute renal failure on drug metabolism.Consequences of renal failure on non-renal clearance of drugs.Brain-kidney crosstalk.Antibiotic Dosing in Patients With Acute Kidney Injury: "Enough But Not Too Much".Influence of kidney disease on drug disposition: An assessment of industry studies submitted to the FDA for new chemical entities 1999-2010.Practical considerations to drug dosing in children with acute kidney injury.Influence of acute and chronic kidney failure in rats on the disposition and pharmacokinetics of ZYAN1, a novel prolyl hydroxylase inhibitor, for the treatment of chronic kidney disease-induced anemia.[Antibiotic dosing for renal function disorders and continuous renal replacement therapy].Doripenem dosing recommendations for critically ill patients receiving continuous renal replacement therapy.Population pharmacokinetics of unbound mycophenolic acid in pediatric and young adult patients undergoing allogeneic hematopoietic cell transplantation.Effect of thymoquinone on hepatorenal dysfunction and alteration of CYP3A1 and spermidine/spermine N-1-acetyl-transferase gene expression induced by renal ischaemia-reperfusion in rats.Acetaminophen clearance during ex vivo continuous renal replacement therapies.Use of Estimating Equations for Dosing Antimicrobials in Patients with Acute Kidney Injury Not Receiving Renal Replacement Therapy Reduced clearance ofε-acetamidocaproic acid in rats with acute renal failure induced by uranyl nitrate

P2860

Q27027552-097571BB-1A76-4D2E-BFF0-6217158EB4BE Q34133346-0D47997B-8342-481B-A44B-B940D6725416 Q34596658-B4A0C1AD-1735-4EAF-9C68-E3F2384F742A Q36333140-8E869C1D-5275-46E1-A77F-2898AFDB927E Q37252494-0F91ACFD-5EB1-40DB-B4B7-42C8BA0CB220 Q37645239-729FDEF5-2CDB-42BF-9A33-639752AAECBD Q37733572-A348DDDA-B166-4B8B-A82D-D28E616ACDD1 Q37846092-E8042F04-6F21-4645-9CCA-5B369A1B091E Q38107784-B2C2007F-6B98-4ED4-A311-2F297E885CDA Q38145416-AC76FAB4-3401-4D90-BEA7-8D412A2C3856 Q38214827-71C045CC-1874-41BB-82A3-F925CEFDFACE Q38231896-8917BDCB-BF3A-4306-98AD-D31B91780406 Q38261172-834F2EBD-E85B-4A8F-91B3-CAE81624BEA7 Q38560098-ECE6FDEF-C7A6-4EE6-B7B0-FD612C707CB6 Q38585496-8D930115-C603-461F-8853-84D0C0B4644C Q39044558-6EC1D4F8-2CA8-485F-A8A0-A2C9DC71B65B Q41379961-452332FB-59C9-4AE0-BCDE-5C8618FF0D74 Q42257467-D32BD369-36A3-4B94-B77E-6F8297DB6C05 Q46372141-F983E6B0-34DC-4001-AF04-A00AE5F78F81 Q46598152-A7582618-BAF4-414D-8E49-18EB751D8ACC Q48141278-E272CC26-A898-4D66-BF95-29E160F0C434 Q58788362-069A0C76-95EE-4814-8FEC-498847BB509C Q58854618-18EDDD34-67E0-43FB-844E-BA0B469208E6

P2860

Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury.

http://www.wikidata.org/entity/Q37336958

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury.

@en

Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury.

@nl

type

label

Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury.

@en

Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury.

@nl

prefLabel

Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury.

@en

Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury.

@nl

P1433

Q37336958-36FB62BA-7E39-4056-A0EA-2116CC19060A

P1476

Q37336958-A654F87D-40B5-476E-9B9A-820AD41EA283

P2093

Q37336958-6F02002B-0500-422C-A83A-AA0B7EB19DA6

Q37336958-8FFC8946-95FA-4035-8DE7-420AE1BCD012

Q37336958-E3B71421-E7A4-4F3A-838A-378CAF0E48F2

P2860

Q37336958-0D3EDB65-4E43-4740-A871-4722D2E86B0F

Q37336958-13EAF715-B346-4438-86F0-2425B0A6B25B

Q37336958-1B50D306-3F9E-44EB-AEA0-6A5C87892625

Q37336958-2347B9A9-DDF8-4671-82F3-0F8C7EF35AF5

Q37336958-2C5E4D36-26D0-4176-9817-B15473A16A86

Q37336958-2FB932D5-91A3-4807-AB96-D0202E366E19

Q37336958-33F64BC2-EF4B-4749-BFAA-3B9006D95040

Q37336958-35601E1B-B3EA-48A8-8957-3411CB5237F3

Q37336958-36ECA11A-E1F7-4800-B469-AEC542047AE6

Q37336958-38B828DE-F1A2-4741-B9F8-1475D97E12F1

P2888

Q37336958-E9EFDCEF-8AE7-4FBB-8539-86DF4DE7A5AC

P304

Q37336958-E74ABEE5-99D9-4FB6-BE59-A48D54A9BF12

P31

Q37336958-3B700E61-1370-402D-B87A-ECF49500194E

Q37336958-B6C4AABA-5C19-4646-9C0A-BEF25B84AF16

P356

Q37336958-ABEEF536-AE5E-4BED-B0E2-CFE7CE686E71

P433

Q37336958-06FE7412-9502-4CE8-A268-BC17E17E4475

P478

Q37336958-79ECBB98-914A-40FB-810A-21219B181DEF

P577

Q37336958-FAF3F827-2F91-4DAC-8594-86FC27896969

P5875

Q37336958-55C72F5C-BB15-4EE2-818E-CB36F51CEA55

P6179

Q37336958-5F16B4B2-6278-4111-877C-A6314A942B54

P698

Q37336958-85DEE039-C853-4298-8F2C-8BAB8D64069D

P921

Q37336958-6E300860-7EC3-4F5D-AD35-711AA0026160

Q37336958-7B671EA8-7118-4619-85C4-3FD47975EFA2

P932

Q37336958-AF1BDBE6-33B8-4A22-89EF-22EFC521D0DB

P356

P1433

P1476

Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury.

@en

P2093

A Mary Vilay

http://www.w3.org/2001/XMLSchema#string

Bruce A Mueller

http://www.w3.org/2001/XMLSchema#string

Mariann D Churchwell

http://www.w3.org/2001/XMLSchema#string

P2860

Dose adjustment in patients with liver disease

The pharmacokinetics of morphine and morphine glucuronides in kidney failure

Disposition of infusions of atracurium and its metabolite, laudanosine, in patients in renal and respiratory failure in an ITU

Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer

Elimination of organic anions in response to an early stage of renal ischemia-reperfusion in the rat: role of basolateral plasma membrane transporters and cortical renal blood flow

The effect of chronic renal failure on hepatic drug metabolism and drug disposition.

Downregulation of hepatic cytochrome P450 in chronic renal failure.

Cardio-respiratory toxicity of propoxyphene and norpropoxyphene in conscious rabbits.

Factors affecting the expression and function of P-glycoprotein in rats: drug treatments and diseased states.

The pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure.

P2888

P304

235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/CC7093

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23553746

http://www.w3.org/2001/XMLSchema#string

P6179

1020332657

http://www.w3.org/2001/XMLSchema#string

P698

19040780

http://www.w3.org/2001/XMLSchema#string

P921

acute kidney injury

pharmaceutical preparation

P932

2646335

http://www.w3.org/2001/XMLSchema#string